Cancer Research in Australia: an overview of funding for cancer research projects and programs in Australia 2012-2020, includes new data, describes the number of research projects and programs directly funded and the amount of funding that has been provided.

This handbook has been written to help health professionals support Aboriginal and Torres Strait Islander people with breast cancer. Increasing the understanding of breast cancer may help to encourage earlier investigation of symptoms, and contribute to the quality of life of people living with breast cancer.

A conceptual framework for cancer care during a pandemic incorporating evidence from the COVID-19 pandemic: Review and update July 2022. Incorporating evidence review to June 2021 was prepared and produced by Cancer Australia.

With the assistance of Aboriginal and Torres Strait Islander people, Cancer Australia has compiled answers to Frequently Asked Questions (FAQs) about the COVID-19 vaccines for people who have been affected by cancer.

This Tip Sheet provides practical advice for cancer care specialists and other health professionals to optimise culturally safe and responsive communication with Aboriginal and Torres Strait Islander patients, their families and carers.

This report provides findings from an analysis of Medicare Benefits Schedule (MBS) data to investigate the impact of COVID-19 on cancer-related medical services and procedures in Australia.

This information is for women who have been treated for early breast cancer or ductal carcinoma in situ (DCIS) and their carers. It provides information about shared follow-up and survivorship care, including the benefits of shared care and who is involved.

This report provides findings from an analysis of Medicare Benefits Schedule (MBS) data for the months January 2020 to June 2020 to understand where changes in the number of cancer-related services have occurred, and the types of services affected during the COVID-19 pandemic.

Cancer Australia's Annual Report for the 2019-2020 reporting period

The COVID-19 pandemic has prompted unprecedented changes in cancer care across the cancer care pathway and in many parts of the oncology sector.

The summary of evidence outlines the evidence base that supports and informs Cancer Australia’s Shared follow-up and survivorship care model for women with low-risk endometrial cancer.

This resource is for all members of the shared care team. It outlines the roles and responsibilities for the specialist and primary care practitioner/s, and their respective teams, in the commencement and delivery of shared follow-up care for low-risk endometrial cancer.

This resource is for women who have completed treatment for low-risk endometrial cancer. It provides general information and guidance on living well following treatment.

This conceptual framework uses published data and guidance to explore system-wide approaches to cancer management during the COVID-19 pandemic.

This evidence report outlines the methodology undertaken to develop Investigating symptoms of lung cancer: a guide for all health professionals (2020).

The guide assists health professionals in the identification and appropriate investigation of symptoms and signs of lung cancer, and supports the timely referral of patients into the multidisciplinary diagnostic pathway.

This resource outlines the roles and responsibilities of the specialist and GP, and their respective teams, in delivering shared follow-up and survivorship care for patients with early breast cancer and DCIS.

Cancer Australia’s seven Principles for shared follow-up and survivorship care for low-risk endometrial cancer are designed to underpin the delivery of shared follow-up and survivorship care for low-risk endometrial cancer by health professionals and health services.

Rapid access request is designed to be used by the General Practitioner (GP) and specialist when follow-up raises a clinical issue requiring urgent specialist consultation or advice.

This guide was developed to assist General Practitioners (GPs) in managing aspects of follow-up care and support for women following completion of active treatment for low-risk endometrial cancer. It provides a general guide to be followed subject to the clinician’s judgement in each individual case.

The resource provides information on the symptoms of lung cancer and the importance of early assessment by a GP or healthcare worker.

This information has been developed to support a discussion with a woman about ovarian cancer, for women at high or potentially high risk. Information for women at average (population) risk is also included.

This guide aims to improve the outcomes and experiences of people affected by lung cancer in Australia by supporting the uptake of five key principles in lung cancer care. 

An overview of sarcoma including types, symptoms, risk factors, diagnosis, treatment and finding support.

The Lung Cancer Framework is a national resource for health professionals and service providers who are involved in the care and treatment of people affected by lung cancer across Australia.

The purpose of this Position Statement is to provide information and recommendations on genetic testing for women diagnosed with invasive epithelial ovarian cancer, based on available evidence and on consensus.

This resource has been superseded in full or in part by the Guidance for the management of early breast cancer website.

An overview of mesothelioma including types, symptoms, risk factors, diagnosis, treatment and finding support.

Knowing your breasts could save your life - a double sided postcard aimed at younger women, and information about how finding breast cancer early is the best chance of surviving the disease. Symptoms and what to look for are listed.

A resource to help support women diagnosed and treated for breast cancer, who may experience menopausal symptoms. This booklet provides information about menopause and its symptoms, and describes some of the physical and emotional changes experienced by women with breast cancer.

A guide for Aboriginal and Torres Strait Islander people and their families, which contains information to help people understand more about lung cancer. This booklet is designed to be used as a hard copy resource. Order your copy below. 

This information sheet has been developed to assist women who have been diagnosed with breast cancer, and offers information around practice 11 from the Cancer Australia Statement – Influencing best practice in breast cancer.

This information sheet has been developed to assist women who have been diagnosed with breast cancer, and offers information around practice 1 from the Cancer Australia Statement – Influencing best practice in breast cancer.

This information sheet has been developed to assist women who have been diagnosed with breast cancer, and offers information around practice 3 from the Cancer Australia Statement – Influencing best practice in breast cancer.

This information sheet has been developed to assist women who have been diagnosed with breast cancer, and offers information around practice 5 from the Cancer Australia Statement – Influencing best practice in breast cancer.

This information sheet has been developed to assist women who have been diagnosed with breast cancer, and offers information around practice 7 from the Cancer Australia Statement – Influencing best practice in breast cancer.

This information sheet has been developed to assist women who have been diagnosed with breast cancer, and offers information around practice 9 from the Cancer Australia Statement – Influencing best practice in breast cancer.

Cancer Australia, the Government’s national cancer control agency, aims to reduce the impact of cancer, address disparities and improve outcomes for people affected by cancer, by leading and coordinating national, evidence-based interventions across the continuum of care.

The National Framework for Gynaecological Cancer Control identifies priority areas for action across the gynaecological cancer control continuum, including prevention, screening, diagnosis, treatment, follow-up, supportive and palliative care, and research.

A flyer for Aboriginal and Torres Strait Islander women about cervical cancer.

An update on Cancer Australia's work in gynaecological cancers as at 24 February 2016.

This resource has been designed to support Aboriginal and Torres Strait Islander Health Workers and Health Practitioners to conduct an Our Lungs, Our Mob workshop for community members. The workshop aims to increase awareness of the symptoms of lung cancer and the benefits of early diagnosis.

Cancer Research in Australia: an overview of funding initiatives to support cancer research capacity in Australia 2006 to 2011 is the first national report of its kind. It presents combined findings from Cancer Australia’s National Audits of funding for cancer research.

The evidence summary summarises the key findings from the systematic review of the Management of women with stage IB2 cervical cancer with treatments other than chemoradiotherapy.

The evidence summary summarises the key findings from the systematic review which compares sentinel lymph node biopsy with complete inguinofemoral lymph node dissection in the treatment of women with early stage vulval cancer.

This is a combination of two DVDs that aim to get people looking out for the symptoms of lung cancer.  

Let’s yarn about lung cancer provides information from health professionals as well as stories form people who live with risks or have experienced possible symptoms of lung cancer. 

The handbook provides information about the lung cancer journey including symptoms,  treatment options and after-treatment care.

This resource, including the Risk of Malignancy Index, provides information to assist clinicians identify those women who should be referred to a gynaecological oncologist. This 2019 second edition is published with minor amendments.

Cancer Australia's Strategic Plan outlines the role of Cancer Australia, future trends and challenges in cancer and Cancer Australia's strategic goals for 2014-2019.

Risk factors for lung cancer: an overview of the evidence is Australia’s first comprehensive, evidence-based summary of factors related to a person’s risk of developing lung cancer, and is based on a systematic review of the international literature commissioned by Cancer Australia.

A summary of the highlights - Cancer Research in Australia: an overview of funding to cancer research projects and research programs in Australia, 2006 to 2011.

Cancer Research in Australia: an overview of funding to cancer research projects and research programs in Australia 2006 to 2011 presents the findings of an audit of funding to cancer research projects and programs in Australia.

Best practice approaches to the management of lung cancer in Australia: A review of the literature - consolidates the research and findings undertaken by Cancer Australia on best practice service delivery approaches to lung cancer care in Australia.

For this systematic review, CNS metastases from metastatic (secondary) breast cancer included metastases in the brain and in the spinal cord (including metastatic spinal cord compression), and both parenchymal and meningeal (leptomeningeal) metastases. Fifty seven citations were included in the review for the five primary research questions.

Cancer Australia's Annual Report for the 2012-2013 reporting period

Cancer Australia has developed a new resource My breast cancer journey: a guide for Aboriginal and Torres Strait Islander women and their families which outlines the clinical management of the early breast cancer journey to support Aboriginal and Torres Strait Islander women with breast cancer and their families.

This resource has been superseded in-full by the Principles of shared follow-up care for early breast cancer.

Shared care roles and responsibilities of shared care clinical teams

Shared care information sheet for health professionals

Guide for women with metastatic (secondary) breast cancer is the key information resource for all women diagnosed with metastatic breast cancer.

This information has been developed to help you understand the signs and symptoms of lymphoedema following treatment for cancer and what you can do to help manage the condition if you develop it.

An overview of kidney cancer including types, symptoms, risk factors, diagnosis, treatment and finding support.

An overview of myeloma including types, symptoms, risk factors, diagnosis, treatment and finding support.

An overview of stomach cancer including types, symptoms, risk factors, diagnosis, treatment and finding support.

An overview of thyroid cancer including types, symptoms, risk factors, diagnosis, treatment and finding support.

An overview of bowel cancer including types, symptoms, risk factors, diagnosis, treatment and finding support.

An overview of breast cancer including types, symptoms, risk factors, diagnosis, treatment and finding support.

An overview of leukaemia including types, symptoms, risk factors, diagnosis, treatment and finding support.

An overview of lung cancer including types, symptoms, risk factors, diagnosis, treatment and finding support.

An overview of melanoma including types, symptoms, risk factors, diagnosis, treatment and finding support.

In June 2012, Cancer Australia held a forum to discuss factors influencing the uptake of the evidence-based chemotherapy recommendations outlined in the Clinical practice guidelines for the management of women with epithelial ovarian cancer.

This resource has been superseded in-full by Investigating symptoms of lung cancer: a guide for all health professionals (2020).

Report to the nation – breast cancer provides an overview of current knowledge about breast cancer in Australia and includes a summary of national statistics on breast cancer in Australia from the Australian Institute of Health and Welfare and Cancer Australia report Breast cancer in Australia: an overview unless otherwise specified.

This document provides a summary of national statistics on cervical cancer in Australia from the Australian Institute of Health and Welfare and Cancer Australia report Gynaecological cancers in Australia: an overview.

This document provides a summary of national statistics on uterine cancer in Australia from the Australian Institute of Health and Welfare and Cancer Australia report Gynaecological cancers in Australia: an overview.

Report to the nation – gynaecological cancers 2012 presents an on-line snapshot of information about incidence, mortality and survival for gynaecological cancers in Australia, using the latest available data.

This resource has been developed to support women (and their partners) in understanding and addressing issues of intimacy and sexuality following the diagnosis and treatment of gynaecological cancer. It aims to empower women so they can ask questions that they may otherwise avoid asking due to embarrassment or other concerns.

This resources support the delivery of the unit of competency: HLTAHW036 - Provide information and support to Aboriginal and Torres Strait Islander women with breast cancer.

This resources support the delivery of the unit of competency: HLTAHW036 - Provide information and support to Aboriginal and Torres Strait Islander women with breast cancer.

A systematic review was undertaken to identify literature published from January 2007 to August 2010 on the use of bisphosphonates in women with early breast cancer.

Understanding your family history of breast or ovarian cancer can provide an indication of your chance of developing either disease.

A systematic review was undertaken to identify literature published between January 2003 and April 2010 on risk management strategies for women at high risk of ovarian cancer. Risk management strategies include surveillance, risk-reducing salpingo-oophorectomy (RRSO), tubal ligation and chemoprevention with the oral contraceptive pill (OCP).

This clinical practice guideline includes statements and recommendations based on available, high-level evidence about the use of hypofractionated radiotherapy for the treatment of women with early (operable) breast cancer.

A systematic review was undertaken to identify literature published from January 2007 to April 2010 on the use of bisphosphonates in women with advanced breast cancer.

A 4-page summary brochure summarising key results and recommendations arising from the report Multidisciplinary cancer care: a national audit 2006.

There have been a number of proposed advantages for follow-up care after treatment for early breast cancer, including early detection of a recurrence or new primary breast cancer, monitoring of treatment-related toxicities and provision of psychosocial support.

Report from National Breast and Ovarian Cancer Centre* and Victorian Cancer Registry reporting on the development and testing of a means of collecting Tumour, Node and Metastases (TNM) stage information for breast cancer by population based cancer registries. Includes an evaluation of the accuracy and completeness of the resulting TNM data.

Follow-up has been defined as “a set of visits and examinations conducted in a systematic manner in the perspective of a pre-defined program”.While some common elements are included in most follow-up regimens, they have usually been developed by consensus or to reflect the approach of individual institutions, rather than on the basis of evidence

This clinical practice guideline, based on high-level evidence, provides clinicians with guidance about the use of chemotherapy in the management of women with advanced breast cancer.

A breast cancer diagnosis can be devastating for many women and their families, irrespective of the age of the woman at diagnosis. This module addresses the issues that need to be considered when communicating with younger women with breast cancer.

This information has been developed to support a discussion with a woman concerned about her family history and covers surveillance for ovarian cancer for women at high or potentially high risk.

A clinical practice guideline developed by NBOCC*. This document supplements guideline recommendation 25 about follow-up care contained in the Clinical Practice Guideline for the Management of Early Breast Cancer, 2nd edition 2001.

This audio CD provides information to men about supporting a woman through early breast cancer.

This information covers screening for ovarian cancer i.e. the testing of women at population risk who have no symptoms that might be ovarian cancer. It has been developed to support discussion with a woman about screening for ovarian cancer.

National Breast and Ovarian Cancer Centre (NBOCC)* developed these breast cancer specific data items for clinical cancer registration and data dictionary definitions to facilitate comparative analysis and, where appropriate, data pooling.

This resource has been superseded in part or in full by the Consumer Involvement Toolkit. 

This resource has been superseded in part or or in full by The psychosexual care of women affected by gynaecological cancers.

A full report on the National Multidisciplinary Care (MDC) Demonstration Project, National Profile Study of Multidisciplinary Care and Observational Study of Multidisciplinary Care. (368 pages)

This document supplements guideline recommendation 9 about axillary node dissection (page 8) and information about sentinel node biopsy (page 57) contained in the Clinical practice guidelines for the management of early breast cancer, 2nd edition 2001.

A total of 4,979 Australian women with early invasive breast cancer were treated by breast surgeons participating in the National Breast Cancer Audit (NBCA) in 2007, the majority of whom were full members of the Breast Section of the Royal Australasian College of Surgeons.

A DL flyer providing information about the symptoms of ovarian cancer.

This resource has been superseded in part or in full by Cancer Australia's ovarian cancer awareness information.

This workshop module aims to provide health professionals with an understanding of best practice relating to the management of secondary lymphoedema.

This booklet is for younger women diagnosed and treated for breast cancer who may be at risk of early menopause. This resource has been superseded in-full or in-part by,

Synoptic report card as part of PAT-1 The pathology reporting of breast cancer: a guide (3rd edition) (952.96 kB)

This guide for pathologists, surgeons, radiologists and oncologists has been updated to reflect the latest evidence and consensus opinion in relation to the handling, examination and reporting of invasive carcinoma and ductal carcinoma in situ (DCIS). Includes updated versions of synoptic reports for invasive carcinoma and DCIS.

Synoptic reporting of ductal carcinoma insitu form, as part of PAT-1 The pathology reporting of breast cancer: a guide (3rd edition) (952.96 kB)

A clinical practice guideline developed by NBOCC*. This document supplements guideline recommendations 22, 24a and 24b about the use of endocrine therapy in Clinical Practice Guidelines for the Management of Advanced Breast Cancer, 2nd edition, 2001 (page 9).

This information has been developed in Vietnamese to help you understand the signs and symptoms of lymphoedema following treatment for cancer and what you can do to help manage the condition if you develop it.

Lymphoedema - what you need to know (Chinese)

Lymphoedema - what you need to know (Italian)

If you have been diagnosed with lymphoedema you may have many questions about your condition. Talking to your doctor is important, but this brochure may also be able to answer some of your questions.

This information has been developed in Arabic to help you understand the signs and symptoms of lymphoedema following treatment for cancer and what you can do to help manage the condition if you develop it.

This information has been developed in Italian to help you understand the signs and symptoms of lymphoedema following treatment for cancer and what you can do to help manage the condition if you develop it.

A systematic review has been undertaken to identify evidence for the administration of neoadjuvant chemotherapy before cytoreductive surgery is performed. Twenty-eight articles were eligible for inclusion in the review (two systematic reviews and 24 comparative trials). 34 page document.

Review of research evidence on secondary lymphoedema: Incidence, prevention, risk factors and treatment

The National Service Delivery Framework for Adolescents and Young Adults with Cancer provides a national framework for quality local care for adolescents and young adults.

Report from a plenary symposium held at the 34th Annual Scientific Meeting of the Clinical Oncological Society of Australia. 17 page document.

The aim of this review was to compare third generation aromatase inhibitors (AIs) to antioestrogens and progestins in the treatment of post-menopausal women with hormone receptor-positive metastatic breast cancer.

This document is an update of Chapter 6 and Appendix G contained in the Breast imaging: a guide for practice, 2002 (resource code BIG).

This review was designed to update the report A Systematic Review of Intraoperative Radiotherapy in Early Stage Breast Cancer published in 2002 by ASERNIP-S (Australian Safety and Efficacy Register of New Interventional Procedures - Surgical). 3 page document.

This document is an update of Chapter 6 and Appendix G contained in the NBCC** Breast imaging: a guide for practice, 2002 (resource code BIG). ** In February 2008, National Breast Cancer Centre (NBCC), incorporating the Ovarian Cancer Program, changed its name to National Breast and Ovarian Cancer Centre (NBOCC).

Information for women, family and friends about locally advanced breast cancer.

DL leaflet on ovarian cancer in Chinese.

DL leaflet on ovarian cancer in Italian.

This information has been developed to help you understand and make decisions about hormonal therapies for the treatment of breast cancer.

Breast cancer in Australia: an overview, 2006 brings together under one cover the most recent information available on the epidemiology, public health and health services impact of breast cancer in Australia. 96 page document.

Recommendations for aromatase inhibitors as adjuvant endocrine therapy for post-menopausal women with hormone receptor-positive early breast cancer.

Information for men with breast cancer

A report and recommendations from a National Breast Cancer Forum series - July 2006

Full report on the audit of multidisciplinary cancer care in Australia. The audit identifies impediments to the national uptake of multidisciplinary care for cancer treatment planning and makes recommendations to improve the uptake and implementation of multidisciplinary cancer care.

This report builds, replicates and extends the findings of the Evidence relevant to guidelines for the investigation of breast symptoms: first edition released in 1997.